Member Info for PM2022

Freddy,

Not everyone can drive. Unless it is Adam then pointless imo as it will send us backwards.

Most LTH are down here but no reason why this cannot get to at least 15p then we can see if it is worth holding or not depending on how good the news is.

Also your opinions are contradictory. Val has reached 74p and 65p and was stable much higher if you had that view then why are you still holding on. You make no sense.

Rubbish because the clinical trials were completed 3 years back. We know the old BOD handled it poorly and took time and this BOD made errors just by giving it to TRX. Regardless, they have spent the last 3 years working on it and raising funds so I believe they have the funds and if the merger completes it will proceed.

Valirx is not just about 201 and I think CLX is the other big one. News on that could be transformational as Val would be looking for an early deal at some stage which could bring 10s millions in upfront payments.

It is all relative our market cap is just 6 million. A few million plus milestones of over 65 million would be enough to make this fly.

Who is the ace Freddy and have they said they would do it?

Neil,

So you admit you think the SP will go up. No way you would hold if you felt it would go down.

You can claim what you want but the bottom line is you have your agenda. The facts are you hold because you see potential that you will see more growth from here than losses.

At least we both agree on the same thing.

BOD has it all to prove but we all know the potential. It could all come good at roughly the same time 201 deal, CLX update and maybe some contracts and VAL goes past 20p comfortably.

I think 201 is very close which is why I call for a bit more patience. No logic in spending months proceeding with a merger if it was going to fail. We can judge soon either way.

I would expect some positive outcomes soon. Either way at this price it seems a good risk vs reward.

HI Neil,

Not sure why you contradict. If you see no value at this price then sell out and go. IF you claim to be a holder then why are you holding? Clearly you think the SP is more likely to go up than down.

The other side is you have an agenda here. The company is significantly undervalued so when the time comes I expect a significant move up. Look at HE1 that at one point last week was up 1000% from the lows.

We will see how it goes with the BOD personally happy to wait until the end of Feb/March so no point constantly moaning all day long.

Hi Neil,

Give it a rest. In your case move on because you have no reason to be on this board.

He is a toxicologist. Therefore his real skills lie in pre-clinical work not at the evaluation stage. I can see why it would be a waste of his time as the compounds need to get through the evaluation stage first and that will not make SP go up for a while.

Could he be preparing to take on CLX for toxicology studies? Nobody knows but people only think of outcomes because they have no idea what alternative outcomes are.

Peer review for 201 has no relevance because a deal is a deal so if payments come through plus funding for trials and milestones then it matters not. TRX would have done the DD already. Once much larger trials are done then they can do that.

Yeah but what stage trials was it? It needs full phase 2b trials but nevertheless it would still be worth good money as any compound to get to this stage costs 10s million in research and development costs let alone previous good results . Find me a phase 2 oncology drug worth at least less than several 10s million pounds? The reason why TRX investors would spend about 15/20 million on trials and agree to pay Valirx 65 million if it gets to market plus royalties plus expenses is because it has the potential to generate huge revenue.

We just need news and we will be rising fast.

Because the initial data for CLX is very strong with nearly a 20 year patent. Even Adam was thinking 10/20 million upfront payments ignore the huge milestone payments. It has to be worth a few times our market cap alone although more work needs to be done. Even 401 has a chance to complete.

201, I think that alone is worth the multiples of our market cap if it gets signed. Then the lab as well has potential. At this market cap I would be surprised if this does not multibag soon.

6 million market cap. Even if it dropped it would only take one or two pieces of small news to get to this market cap. We still have a selection of compounds all worth money so we should never be at this price.

More likely when big news arrives like the 201 deal we will rise like HE1 as the market cap is a joke at the moment.

It is either we remain where we are or we rise big if 201 is signed. Those milestones are very significant at this market cap and would allow a takeover bid to come if we don't have a decent market cap. The cash will develop the new compounds more.

Imagine a big biotech putting in a 20 million plus offer for a potential 65 million for 201 plus royalties, CLX, Imogen and other new compounds plus cash that we would have plus the additional potential milestones from 401 if that completes.

Why don't they negotiate an offer for the company to help the SP go up but I guess first they need to deliver. Not sure the current BOD would ever consider selling this company so they need to deliver.

One can say the same about many stocks including HE1 where they took jack all in the placing although I agree she should have purchased more in this situation.

I just don't see how it can be a scam as it would involve so many different individuals maybe more than 30/40 people across different companies and departments.

HE1 now 1p after a recent placing at 0.25 having dropped to 0.19p.

I think if 201 completes soon we can do 500% from these prices so the reward is still very favourable.

I agree but my view is that we should give it until the end of March to see if 201 completes which I anticipate should happen by then. If that happens I think more news will come and perception can change. Changes should always be a last resort unless you are loaded with cash otherwise it can often slow down progress even more.

Given the time to really understand the strategy, products building connections and to change the strategy can take years and cost a significant amount.

The danger is you go back 3 years if you do changes which will take time, resources and costs. It may even have a negative impact on the 201 deal which I think is the real catalyst at the moment. We got a year to make use of it so I think the end of March is a fair timeline. If they still cannot get something over the line then we have no choice.

All about perception. Lots of buyers those days with far less in the pipeline and 10 times the price.

The true value of the company should be significantly higher based on pipeline/products. This is why the likes of Adam were buying here even at 40/50p.

We might not go as high anytime soon but I see significant value here at least to multibag.

The smart ones will understand this and will look to add this price imo.

If 201 failed and no other positives at all then yes it can at the point of a future placing but more likely in the next 1 year we get several positives and 201 deal will complete soon.

Nothing is risk free I would think this has roughly the same chance to do 500% in the next year as it does to go to 1p. Not a bad risk to reward.

Talking about taking things out of context.

I predict Valirx will be placing in 2024, 2025, 2026 or 2027 with a price of 1p, 10p, 20p, 30p or more.

Even if it is 400-500 or 1000% more or less or a few months or years out call me right when it happens.

The perception that people give to all this is nonsense. Hopefully people get the drift.